$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Salarius Pharmaceuticals, Inc. – SLRX

Group 1 - Monteverde & Associates PC is investigating Salarius Pharmaceuticals, Inc. regarding its proposed merger with Decoy Therapeutics, Inc. [1] - Under the merger agreement, Salarius stockholders would own approximately 14% of the outstanding shares of the combined company [1] - Monteverde & Associates PC has a successful track record in recovering money for shareholders and is recognized as a Top 50 Firm by ISS Securities Class Action Services Report [1][2] Group 2 - The firm is headquartered in the Empire State Building in New York City [1][2] - Monteverde & Associates PC is a national class action securities firm with experience in trial and appellate courts, including the U.S. Supreme Court [2] - The firm encourages shareholders with concerns to contact them for additional information free of charge [2]